Fulcrum Therapeutics FULC
NASDAQ FULC
$3.69 +0.01 (+0.27%)
At close: Oct 2, 2026 · 4:00 PM EDT

Fulcrum Therapeutics (FULC) Selling, General & Administrative (2018 - 2026)

Updated

Fulcrum Therapeutics' Selling, General & Administrative was $7.46 million in Q2 2026, up 9.3% from $6.83 million a year earlier but down 7.9% from the prior quarter.

Analysis

Fulcrum Therapeutics (FULC) Selling, General & Administrative (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Fulcrum Therapeutics' Selling, General & Administrative was $30.4 million through Jun 30, 2026, up 1.5% year-over-year; for FY2025, it was $28.67 million, down 21.4% from FY2024.

  • Selling, General & Administrative has now declined for three consecutive years, though with a five-year compound annual growth rate of 6.0% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $36.45 million in FY2024 (-12.5%), $41.67 million in FY2023 (-0.1%), $41.69 million in FY2022 (+36.6%) and $30.52 million in FY2021 (+42.7%).
  • Quarterly Selling, General & Administrative has moved between $6.83 million (Q2 2025) and $11.52 million (Q1 2023) over five years.
  • Compared with a year earlier, Selling, General & Administrative was higher in two of the last eight quarters, with an average decline of 11.5%.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q1 2022 (growth of 95.7%); the worst was Q2 2025 (a decline of 33.4%).
  • Per Business Quant data, FULC's Selling, General & Administrative in the three quarters before Q2 2026 was $8.1 million (Q1 2026), $7.28 million (Q4 2025) and $7.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Fulcrum Therapeutics 281.49 Mn 281.49 Mn - 7.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.46 Mn
Mar 31, 2026 8.10 Mn
Dec 31, 2025 7.28 Mn
Sep 30, 2025 7.56 Mn
Jun 30, 2025 6.83 Mn
Mar 31, 2025 7.00 Mn
Dec 31, 2024 7.72 Mn
Sep 30, 2024 8.42 Mn
Jun 30, 2024 10.25 Mn
Mar 31, 2024 10.06 Mn
Dec 31, 2023 9.86 Mn
Sep 30, 2023 9.96 Mn
Jun 30, 2023 10.32 Mn
Mar 31, 2023 11.52 Mn
Dec 31, 2022 10.13 Mn
Sep 30, 2022 9.71 Mn
Jun 30, 2022 11.10 Mn
Mar 31, 2022 10.76 Mn
Dec 31, 2021 9.71 Mn
Sep 30, 2021 8.63 Mn
API Access

Fulcrum Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=FULC&period=max&api_key=YOUR_API_KEY